MedPacto, Inc. (KOSDAQ:235980)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,510.00
-40.00 (-0.72%)
Feb 27, 2026, 3:30 PM KST
Market Cap188.86B +61.3%
Revenue (ttm)2.47B
Net Income-14.57B
EPS-426.07
Shares Out34.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume199,292
Average Volume463,811
Open5,470.00
Previous Close5,550.00
Day's Range5,450.00 - 5,800.00
52-Week Range2,750.00 - 8,650.00
Beta0.60
RSI39.07
Earnings DateMar 19, 2026

About MedPacto

MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 235980
Full Company Profile

Financial Performance

Financial Statements